Biopharma Policy
-
From Copycats to Creators: Decoding India’s ₹10,000 Crore Biopharma SHAKTI Pivot
For decades, India has been the “Pharmacy of the World,” the undisputed heavyweight champion of…
For decades, India has been the “Pharmacy of the World,” the undisputed heavyweight champion of…